Healthtech Solutions Inc. (HLTT) Broadens Portfolio with Acquisition of Varian Bio, Enters Precision Cancer Care Market
Healthtech Solutions is acquiring Varian Biopharmaceuticals, developer of atypical protein kinase C iota inhibitors within thriving precision oncology marketVarian Bio is developing two pre-clinical experimental drugs, VAR-101 for basal cell carcinoma and VAR-102 for a variety of solid tumors, including pancreatic, colorectal and NSCLC.Varian Bio will join MediScan, RevHeart in Healthtech’s portfolio of innovative healthcare technology companies For more than three decades, scientists searched to…